| # | Drug | Count |
|---|---|---|
| 0 | PANTOPRAZOLE | 8 |
| 1 | ACLIDINIUM BROMIDE | 7 |
| 2 | ALBUTEROL SULFATE | 7 |
| 3 | CASTOR OIL | 7 |
| 4 | CICLESONIDE | 7 |
| 5 | FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE | 7 |
| 6 | OMALIZUMAB | 7 |
| 7 | VALSARTAN | 2 |
| 8 | AMLODIPINE | 1 |
| 9 | ASPIRIN | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CASTOR OIL | 7 | 0.0543 |
| 1 | ACLIDINIUM BROMIDE | 7 | 0.0013 |
| 2 | CICLESONIDE | 7 | 0.0007 |
| 3 | FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE | 7 | 0.0001 |
| 4 | OMALIZUMAB | 7 | 0.0001 |
| 5 | PANTOPRAZOLE | 8 | 0.0000 |
| 6 | NILOTINIB | 1 | 0.0000 |
| 7 | RISANKIZUMAB-RZAA | 1 | 0.0000 |
| 8 | ALBUTEROL SULFATE | 7 | 0.0000 |
| 9 | ATORVASTATIN CALCIUM TABLETS | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anti-IgE [EPC] | 7 | 0.0001 |
| 1 | Interleukin-23 Antagonist [EPC] | 1 | 0.0000 |
| 2 | Angiotensin 2 Receptor Blocker [EPC] | 2 | 0.0000 |
| 3 | HMG-CoA Reductase Inhibitor [EPC] | 2 | 0.0000 |
| 4 | Dihydropyridine Calcium Channel Blocker [EPC] | 1 | 0.0000 |
| 5 | beta-Adrenergic Blocker [EPC] | 1 | 0.0000 |
| 6 | Kinase Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Benzodiazepine [EPC] | 1 | 0.0000 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1 | 0.0000 |